undamentalytics Newsletter
Sign in

Pediatrix Medical Group, Inc. cash flow statement

In fiscal 2025, Pediatrix Medical Group, Inc.'s operations generated $271m of cash; it spent $18.5m on capital projects, leaving free cash flow of $253m. It returned $86.7m through buybacks.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations44451131435820577167137207271227
Depreciation and amortisation8979242628323636322224
Stock-based pay3429373339191612121821
Capital spending3926171929323033221817
Free cash flow40548529733817644137104185253210
Free cash flow after stock pay3714562603051372612192173235188
Share buybacks627030214585891287211
Shares issued222316117755433

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: EHC vs MDARDT vs MDCYH vs MD

More: Hospitals stocks compared, Health Care sector, rankings of US companies

Figures from Pediatrix Medical Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pediatrix Medical Group, Inc.